BIORETEC OY - Asset Resilience Ratio
BIORETEC OY (0TN) has an Asset Resilience Ratio of 26.06% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 0TN total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how BIORETEC OY's Asset Resilience Ratio has changed over time. See 0TN total equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down BIORETEC OY's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see BIORETEC OY (0TN) market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €3.04 Million | 26.06% |
| Total Liquid Assets | €3.04 Million | 26.06% |
Asset Resilience Insights
- Very High Liquidity: BIORETEC OY maintains exceptional liquid asset reserves at 26.06% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
BIORETEC OY Industry Peers by Asset Resilience Ratio
Compare BIORETEC OY's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Lucid Diagnostics Inc
NASDAQ:LUCD |
Medical Devices | 6.09% |
|
Business Alignment Public Company Limited
BK:BIZ |
Medical Devices | 0.63% |
|
Somnomed Ltd
AU:SOM |
Medical Devices | 24.67% |
|
T&R Biofab Co. Ltd
KQ:246710 |
Medical Devices | 0.12% |
|
Cleanspace Holdings Ltd
AU:CSX |
Medical Devices | 29.39% |
|
Curvebeam Ai Ltd
AU:CVB |
Medical Devices | 8.27% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
Annual Asset Resilience Ratio for BIORETEC OY (2021–2025)
The table below shows the annual Asset Resilience Ratio data for BIORETEC OY.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 26.06% | €3.04 Million ≈ $3.56 Million |
€11.68 Million ≈ $13.65 Million |
+4.68pp |
| 2024-12-31 | 21.37% | €2.45 Million ≈ $2.87 Million |
€11.47 Million ≈ $13.42 Million |
-7.96pp |
| 2023-12-31 | 29.33% | €3.13 Million ≈ $3.65 Million |
€10.66 Million ≈ $12.46 Million |
+0.22pp |
| 2022-12-31 | 29.11% | €1.02 Million ≈ $1.19 Million |
€3.49 Million ≈ $4.08 Million |
-46.15pp |
| 2021-12-31 | 75.27% | €6.46 Million ≈ $7.55 Million |
€8.58 Million ≈ $10.03 Million |
-- |
About BIORETEC OY
Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; A… Read more